Last reviewed · How we verify
NCT06045377
Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia
NA trial testing Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia in Dyslipidemias in 90 participants. Completed in 5 September 2022.
25 June 2022
Quick facts
| Lead sponsor | Athens General Children's Hospital "Pan. & Aglaia Kyriakou" |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 20 January 2020 |
| Primary completion | 25 June 2022 |
| Estimated completion | 5 September 2022 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia
Conditions studied
- Dyslipidemias — all drugs for Dyslipidemias →
- Children, Only — all drugs for Children, Only →
Sponsor
Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Who can join
Adults 7 to 16, any sex, with Dyslipidemias or Children, Only. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Data concerning the effectiveness od nutraceuticals in children with dyslipidemia are lacking. The aim of the present study was to evaluate the efficacy and safety of the long-term use of a dietary supplement containing red yeast rice (RYR), combined with other natural compounds, in children and adolescents with hypercholesterolemia. A nutraceutical, containing RYR, polycosanols, coenzyme Q10, astaxanthin and folic acid (commercial name: Armolipid), was administered once-daily in 84 children/adolescents with moderate or severe hypercholesterolemia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia.
Garoufi A, Papadaki M, Kalogiannis M, Zerva U, et al · · 2024 · cited 2× · PMID 39766315 · DOI 10.3390/biom14121608
Verify or expand the search:
- PubMed search for NCT06045377
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dyslipidemias
Currently open trials in the same condition.
- NCT07308314 — Taining Golden Lake Comprehensive Chronic Disease Management Initiative · recruiting
- NCT06526273 — PILI 'Āina Household · NA · recruiting
- NCT06797401 — Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia · Phase 2 · recruiting
- NCT06380322 — Military Health and Nutrition Examination Study · recruiting
- NCT06183307 — Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia · NA · recruiting
Other Athens General Children's Hospital "Pan. & Aglaia Kyriakou" trials
Trials by the same sponsor.
- NCT06398912 — Studying Newborns' Brain Activity in the NICU Through a Musical Intervention: the Role of Fundamental Frequency · NA · completed
- NCT03979469 — Opioid Versus Non-opioid Anesthesia for Ambulatory Surgery in Children · Phase 2 · completed
- NCT03131375 — Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia · Phase 2, PHASE3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06045377 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06045377.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing